Webcast/CME - Bone Marrow Failure Syndromes Optimizing Outcomes Worldwide through Disease Understanding

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Myelodysplastic Syndrome

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Myelodysplastic Syndrome

Recent news - Myelodysplastic Syndrome

	Conventional Cytogenetics Usually Adequate Way to Test for Primary Myelodysplastic Syndrome: Presented at ASCP - (DGDispatch)
	Anaemic Patients With MDS Benefit From Erythropoietin, Myeloid Growth Factor Hormones - (DGNews)
	Hypomethylating Agents Show Better Efficacy Than Best Supportive Care in Patients With Myelodysplastic Syndrome: Presented at EHA - (DGDispatch)
	Mutation in TET2 in myeloid cancers - (N Engl J Med)
	Azacitidine Approved in EU for Myelodysplastic Syndromes, AML - (DGNews)

Recent cases - Myelodysplastic Syndrome

	Miliary Tuberculosis with no Pulmonary Involvement in Myelodysplastic Syndromes: A Curable, Yet Rarely Diagnosed, Disease: Case Report and Review of the Literature
	Extensive Myocardial Infiltration by Hemopoietic Precursors in a Patient with Myelodysplastic Syndrome
	A Case of Generalised Cutaneous Granulocytic Sarcoma in an Elderly Patient with Myelodysplastic Syndrome

personal edition > myelodysplastic syndrome > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Bone Marrow Failure Syndromes Optimizing Outcomes Worldwide through Disease Understanding

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	Louis DeGennaro, PhD, Pierre Fenaux, MD, PhD, Aristoteles A.N. Giagounidis, MD, PhD, James G. Herman, MD, Alice Houk, MS and Jaroslaw P. Maciejewski, MD, PhD
Approximate duration:	3 hrs.
Summary points:	This audiovisual presentation discusses the variations in bone marrow failure epidemiology and treatment approaches in different regions of the world; the molecular basis of bone marrow failure syndromes; treatment strategies that target epigenetic and other pathobiological bases for bone marrow failure disorders; strategies to minimise transformation of bone marrow failure syndromes to acute myeloid leukemia; and treatment approaches for bone marrow failure syndrome.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Expiration Date: February 28, 2011.
Other:

Additional Information